Bettersize Launches BeSec for Advanced Biopharmaceutical Characterisation

03 February 2026 | Meritics Ltd

Bettersize Launches BeSec for Advanced Biopharmaceutical Characterisation

Bettersize Instruments is proud to introduce BeSec, a high-performance dual-angle light scattering detector developed to meet the analytical demands of modern biopharmaceutical research, development, and quality control. Designed for seamless integration with SEC systems, BeSec enables accurate, absolute characterisation of protein therapeutics without the need for column calibration.

BeSec delivers absolute molecular weight (Mw) and radius of gyration (Rg) measurements using low- and right-angle light scattering detection. Because molecular weight determination is independent of elution volume, BeSec eliminates reliance on reference standards, providing greater confidence when analysing complex or novel biologics.

For protein-based therapeutics, BeSec supports precise determination of molecular weight, oligomeric state, and the presence of high- and low-molecular-weight aggregates—critical quality attributes (CQAs) closely monitored throughout biopharmaceutical development. The system is ideally suited for the characterisation of monoclonal antibodies, antibody fragments, fusion proteins, and other biologics where structural integrity and aggregation control are essential for safety and efficacy.

Low-angle detection enhances sensitivity and accuracy, particularly for high-molecular-weight species and aggregates that can be challenging to resolve using conventional detectors alone. Fully compatible with any SEC system, BeSec integrates easily into existing workflows, making it a practical upgrade for laboratories operating under regulated or GMP-aligned environments.

By providing reliable, reproducible data and simplifying molecular weight analysis, BeSec supports informed decision-making across formulation development, process optimisation, and batch release testing.

With the launch of BeSec, Bettersize reinforces its commitment to delivering advanced analytical solutions that help biopharmaceutical scientists ensure product quality, consistency, and patient safety.

Available in the UK from Meritics

Other Press Releases from Meritics Ltd